Task: Answer Verification
Input (English): Question: Does exacerbation of headache during dihydroergotamine for chronic migraine alter outcome?
Answer: After controlling for nausea and other factors, headache exacerbation with DHE infusions is not an independent predictor of poor headache outcome and clinicians should not interpret its presence as a reason to stop treatment. The focus of management should be on controlling nausea as it is the most important modifiable factor in achieving a good headache outcome with an inpatient course of IV DHE for chronic migraine.
Output (English): no